News | March 18, 2026
Zydus, Lupin join forces to expand access to semaglutide in India
The deal also includes upfront licensing fees and milestone-based payments from Lupin to Zydus
The deal also includes upfront licensing fees and milestone-based payments from Lupin to Zydus
AstraZeneca says the approval strengthens its push to bring immunotherapy earlier into cancer treatment, where long-term cures are possible
The framework introduces 15 consensus terms and definitions grouped across four core dimensions of skin health
The planned facility, to be built at Samsung’s Bio Campus II, is set to become a launchpad for up to 30 emerging biotech firms
LTTS’ lung digital twin integrates seamlessly with CT imaging workflows, using deep learning to reconstruct a comprehensive 3D digital twin of the lungs
FGFR alterations are prevalent in early-stage bladder cancer, appearing in roughly 70% of intermediate-risk and 40% of high-risk NMIBC tumors
Under the agreement, healthcare professionals in the country will gain access to C2N’s PrecivityAD2 blood test
Previously, Arexvy was authorized for adults 60 and older, and for those 50–59 with heightened risk
This study demonstrates the power of real-time glucose information for people with Type 2 diabetes treated with basal insulin
The expanded ownership is expected to improve access to Cialis for millions of men in Asia affected by ED and BPH
Subscribe To Our Newsletter & Stay Updated
